Working Groups

Latest News

Dr Matthew Dryden on AMR

Executive Committee member Matthew Dryden discusses AMR.

Read More
Flu Survey: IPC Working ...

Please take the IPC Working Group survey on influenza.

Read More


Current Officers

F Amer


Fatma Amer

A Hoepelman


Andy Hoepelman

K Ayaz


Khan Fariduddin Mohammad Ayaz

Z Sekawi


Zamberi Sekawi

All Members

Mamun Al-Mahtab (Bangladesh)
Joop Arends (The Netherlands)
Shafiqul Bari (Bangladesh)
Junaid Bhai (Bangladesh)
Rehab Elsaid (Egypt)
Hakan Erdem (Turkey)
N. Furusyo (Japan)
Noha Hammad (Egypt)
D. Januszkiewicz-Lewandowska (Poland)
Lanjuan Li (China)
T. Lizuka (Japan)
Aouni Mahjoub (Tunisia)
Mojca Matičič (Slovenia)
Syed Ghulam Mogni Mowla (Bangladesh)
Monkez Moteia (Egypt)
Ghada Nasr (Egypt)
N. Nazia (Bangladesh)
Kemal Ozden (Turkey)
Fazle Rabbi Chowdhury (Bangladesh)
W. F. Tang (China)
Adnan Toumi (Tunisia)
P. Zhao (China)

How to Join

Members of an ISAC Member Society are eligible to join any of our Working Groups. If you are a member and would like to join this group, please contact the Chairperson and Secretary (if applicable).

Aims and Objectives

Hepatitis is a serious hazard, leading to morbidity and mortality, and affecting the quality of life. There are many causes of hepatitis both infectious and non- infectious. Hepatitis can be acute or chronic. Infectious agents account for the majority of acute cases: hepatitis C alone accounts for c. 20% of acute cases. Fourteen other families of viruses are responsible also for acute hepatitis. Moreover bacteria, protozoa, parasites, fungi and algae can similarly cause acute hepatitis. As regards chronic hepatitis, in addition to many other causes, viral hepatitis ( hepatitis B with or without hepatitis D, hepatitis C, and hepatitis E) is of special concern. Autoimmune disorders can also lead to chronic hepatitis. We are all quite cognizant that nearly 170 million people worldwide are suffering from chronic HCV infection. Likewise, it is estimated that the global reservoir of HCV infected individuals is in a steady increase, which is not limited to developing countries. In the USA 18,000 new HCV infections occur each year, as reported by the Centres for Disease Control and Prevention (CDC), which corresponds to about one new case every 30 minutes.

The aim of the Hepatitis Working Group is to work together at an international level, in multiple areas related to hepatitis as regards education, and research activities. Special emphasize is to be placed on clinical trials for treatment of HCV patients using newly developed DAAs, and on HCV genotypes which have not been tackled by most of the on-going studies, e. g., genotype 4.

Objectives -

  • To include junior colleagues. When the enthusiasm and creation capabilities of the young colleagues are added to the experience and wisdom of senior colleagues, wonderful things can be accomplished.
  • To hold “Hepatitis Symposium” presented by members of the HWG possibly in all coming meetings, whether national, regional or international.
  • To make intensive efforts for fund raising.
  • To carry out a study about prevalence and risk factors of asymptomatic hepatitis C virus infection in children. After the availability of the new DAAs, perhaps identification of HCV early in childhood can alter the course of the disease. it is also important to take into account the long-term morbidity of the disease. The aim of this study is to identify the prevalence and possible risk factors of asymptomatic HCV infection in children and to detect the underlying signs and symptoms of liver disease associated with asymptomatic HCV in such category of patients.




April 2014 The 3rd Conference of the Federation of Arab Societies of Clinical Microbiology and Infectious Diseases & The 10th Conference of Arab Alliance for Prudent Use of Antimicrobial Agents (ArAPUA), Dead Sea, Jordan. 
September 2014 Towards HCV-Free Community Conference, Zagazig, Egypt.
October 2014 5th SEEC for Chemotherapy and Infection, Bled, Slovenia
December 2014 3rd National Conference on Tropical Medicine & Toxicology, Sylhet, Bangladesh
April 2015 Annual Conference of Zagazig Faculty of Medicine
July 2015 World Congress on Hepatitis. 20- 22 July, Orlando, Forida 2015
November 2015 6th SEEC. Thessaloniki
December 2015 National Conference on Tropical Medicine & Toxicology, Cox Bazar, Bangladesh



Projects / Publications

Epidemiology of Hepatitis C Virus Infection in Egypt.  International Journal of TROPICAL DISEASE & Health 7(3): 119-131, 2015, Article no.IJTDH.2015.065 ISSN: 2278–1005
Immunological mechanisms controlling hepatitis C virus infection
IMMUNE-BASED STRATEGIES FOR TREATMENT AND PREVENTION OF HEPATITIS C VIRUS INFECTION. The International Arabic Journal of Antimicrobial Agents. Vol. 4 No. 1:1 doi: 10.3823/743
Immunological mechanisms controlling hepatitis C virus infection. FEBRUARY 2015. DOI: 10.1016/S2222-1808(14)60633-2
Asian Pacific Journal of Tropical Disease 02/2015; 5(2):85–90. ABSTRACT Hepatitis C virus (HCV)


Last updated: January 25th-2017